Vyara T.
- Country
- Bulgaria
- Department
- Hemodialysis department
Research Overview
Data & Insights
Has run more than one trial at 6 of 212 partner sites.
Specializations
Chronic Obstructive Pulmonary Disease and Severe Asthma
Vyara Tserovska is involved in clinical research focused on obstructive airway disease, including COPD and severe asthma, with attention to bronchodilator-based treatment strategies, inhaled combination therapies, and long-term control of respiratory symptoms.
- Combination inhaled triple therapy
- Severe asthma treatment
- Lung function assessment
Her work also includes comparative evaluation of inhaled formulations and therapies aimed at improving respiratory outcomes in adults with persistent airway disease.
Bronchiectasis and Pulmonary Exacerbations
Her clinical trial activity extends to bronchiectasis, with a therapeutic focus on reducing pulmonary exacerbations and addressing chronic infection-related respiratory burden in patients with structurally damaged airways.
- Bronchiectasis management
- Exacerbation reduction
- Respiratory inflammation
This area reflects involvement in treatment approaches designed to improve stability and symptom control in chronic suppurative lung disease.
Chronic Kidney Disease and Hypertension
Vyara Tserovska is also active in studies of chronic kidney disease and hypertension, with interest in therapies targeting renal protection, blood pressure control, and reduction of kidney-related and cardiovascular complications.
- Albuminuria reduction
- Kidney function preservation
- Blood pressure management
Her research involvement includes cardiometabolic treatment strategies relevant to patients with renal impairment and elevated cardiovascular risk.
Atherosclerotic Cardiovascular Disease
Her research landscape includes atherosclerotic cardiovascular disease, with emphasis on prevention of major adverse cardiovascular events and treatment strategies for patients at heightened vascular risk.
- Cardiovascular risk reduction
- Stroke and myocardial infarction prevention
- Vascular event outcomes
This area aligns with therapeutic interest in lowering the burden of heart, brain, and peripheral vascular complications.
COVID-19 in High-Risk Patients
Her clinical trial portfolio also includes COVID-19 research in nonhospitalized patients at high risk of progression to severe illness, supporting antiviral treatment evaluation in vulnerable populations.
- Early COVID-19 treatment
- High-risk infection management
- Prevention of severe disease
This therapeutic domain reflects involvement in outpatient infectious disease care aimed at limiting clinical deterioration.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.